Osteoporosis is a very common disorder and much has been learnt in recent years about the many pathogenic processes that contribute to bone loss and fragility. Drug treatments are now available to prevent bone loss and reduce fracture, and there are prospects for modifying some of the pathogenic processes themselves. In common with other structures, the tissues of the musculoskeletal system undergo many changes with aging, and some of the commonest skeletal disorders are seen in the elderly. The changes in bone lead to osteoporosis and fractures, whereas muscle changes (sarcopenia) contribute to frailty, and changes in cartilage lead to osteoarthritis.
Conference Article| April 01 2003
Osteoporosis: pathogenesis and clinical intervention
R.G.G. Russell 1
The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedic Surgery, Nuffield Orthopaedic Centre, Headington, Oxford OX3 7LD, U.K.
1To whom correspondence should be addressed (e-mail Graham.Russell@ndos.ox.ac.uk).
Search for other works by this author on:
Biochem Soc Trans (2003) 31 (2): 462-464.
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
G. Mueller, R.G.G. Russell; Osteoporosis: pathogenesis and clinical intervention. Biochem Soc Trans 1 April 2003; 31 (2): 462–464. doi: https://doi.org/10.1042/bst0310462
Download citation file: